Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B244 in Moderate to Severe Acne Vulgaris
NCT07866105Phase 2Not yet recruiting
- Sponsor
- AOBiome
- Start
- Oct 2026
- Primary completion
- Aug 2027
01
Overview
A Phase 2 trial of B244 in acne vulgaris, sponsored by AOBiome. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
B244
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT07866105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07866105.